![](/img/cover-not-exists.png)
A Phase III open-label, randomized, multicenter study of imprime pgg in combination with cetuximab in patients with kras wild type metastatic colorectal cancer
Meyerhardt, Jeffrey A, Grady, Michele M, Lowe, Jamie N, Gargano, Michele A, Huhn, Richard D, Braun, Ada HVolume:
2
Year:
2014
Language:
english
Journal:
Journal for ImmunoTherapy of Cancer
DOI:
10.1186/2051-1426-2-S3-P71
File:
PDF, 132 KB
english, 2014